ABBIE FULK: Open Payments
NPI 1598372328 · GERING, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 30 payments from 17 companies in 2025. Trend: 2023 $226 · 2024 $417 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 3 | $79 |
| Insmed, Inc. | 4 | $73 |
| Pulmonx Corporation | 2 | $56 |
| Travere Therapeutics, Inc. | 4 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Verona Pharma, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $34 |
| Viatris Specialty LLC | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
Products named: Prolastin-C Liquid, Arikayce, CHARTIS CATHETER, FASENRA, DUPIXENT, Ohtuvayre, MAVYRET, YUPELRI.
Industry payments across NE — which companies pay providers there.
